Related references
Note: Only part of the references are listed.Feasibility of global miRNA analysis from fine-needle biopsy FFPE material in patients with hepatocellular carcinoma treated with sorafenib
Jan Peveling-Oberhag et al.
CLINICAL SCIENCE (2015)
Liver transplantation for hepatocellular carcinoma comparing the Milan, UCSF, and Asan criteria: long-term follow-up of a Western single institutional experience
Italo Bonadio et al.
CLINICAL TRANSPLANTATION (2015)
Downstaging of hepatocellular cancer before liver transplant: Long-term outcome compared to tumors within Milan criteria
Francis Y. Yao et al.
HEPATOLOGY (2015)
High serum microRNA-122 level is independently associated with higher overall survival rate in hepatocellular carcinoma patients
Yongqing Xu et al.
TUMOR BIOLOGY (2015)
Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma
Yu-Cheng Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
An oncogenic role of Agrin in regulating focal adhesion integrity in hepatocellular carcinoma
Sayan Chakraborty et al.
NATURE COMMUNICATIONS (2015)
MicroRNA-455 inhibits proliferation and invasion of colorectal cancer by targeting RAF proto-oncogene serine/threonine-protein kinase
Jie Chai et al.
TUMOR BIOLOGY (2015)
Is Resection or Transplantation the ideal Treatment in Patients with Hepatocellular Carcinoma in Cirrhosis if Both Are Possible? A Systematic Review and Metaanalysis
Andrea Proneth et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
A Serum MicroRNA Panel as Potential Biomarkers for Hepatocellular Carcinoma Related with Hepatitis B Virus
Youwen Tan et al.
PLOS ONE (2014)
Association of Serum MicroRNA Expression in Hepatocellular Carcinomas Treated with Transarterial Chemoembolization and Patient Survival
Mei Liu et al.
PLOS ONE (2014)
Survival analysis of patients with stage I and II hepatocellular carcinoma after a liver transplantation or liver resection
Ramanathan M. Seshadri et al.
HPB (2014)
Downregulation of microRNA-214 and overexpression of FGFR-1 contribute to hepatocellular carcinoma metastasis
Jian Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma
Verena Koeberle et al.
EUROPEAN JOURNAL OF CANCER (2013)
MicroRNA-140-5p Suppresses Tumor Growth and Metastasis by Targeting Transforming Growth Factor β Receptor 1 and Fibroblast Growth Factor 9 in Hepatocellular Carcinoma
Hao Yang et al.
HEPATOLOGY (2013)
MicroRNA-140 acts as a liver tumor suppressor by controlling NF-kappa B activity by directly targeting DNA methyltransferase 1 (Dnmt1) expression
Akemi Takata et al.
HEPATOLOGY (2013)
How to decide about liver transplantation in patients with hepatocellular carcinoma: Size and number of lesions or response to TACE?
Gerd Otto et al.
JOURNAL OF HEPATOLOGY (2013)
Differential Stability of Cell-Free Circulating microRNAs: Implications for Their Utilization as Biomarkers
Verena Koeberle et al.
PLOS ONE (2013)
Recurrent hepatocellular carcinoma after liver transplantation - an emerging clinical challenge
Martin-Walter Welker et al.
TRANSPLANT INTERNATIONAL (2013)
MicroRNAs and liver cancer associated with iron overload: Therapeutic targets unravelled
Catherine M. Greene et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Micro RNA Expression Profiles as Adjunctive Data to Assess the Risk of Hepatocellular Carcinoma Recurrence After Liver Transplantation
C. T. Barry et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Number and Tumor Size Are Not Sufficient Criteria to Select Patients for Liver Transplantation for Hepatocellular Carcinoma
T. Piardi et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
MicroRNA-214 inhibits angiogenesis by targeting Quaking and reducing angiogenic growth factor release
Alain van Mil et al.
CARDIOVASCULAR RESEARCH (2012)
Impact of neoadjuvant transarterial chemoembolization on tumor recurrence and patient survival after liver transplantation for hepatocellular carcinoma: a retrospective analysis
Daniel Seehofer et al.
CLINICAL TRANSPLANTATION (2012)
Up-regulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation
Zhong-Bo Han et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma
Florie Borel et al.
JOURNAL OF HEPATOLOGY (2012)
MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma
Tsung-Chieh Shih et al.
JOURNAL OF HEPATOLOGY (2012)
Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation
Zhong-Bo Han et al.
MOLECULAR ONCOLOGY (2012)
DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways
Ioannis S. Vlachos et al.
NUCLEIC ACIDS RESEARCH (2012)
MiR-214 Targets β-Catenin Pathway to Suppress Invasion, Stem-Like Traits and Recurrence of Human Hepatocellular Carcinoma
Hongping Xia et al.
PLOS ONE (2012)
Hepatitis B virus regulates Raf1 expression in HepG2.2.15 cells by enhancing its promoter activity
Yuanyuan Tian et al.
ARCHIVES OF VIROLOGY (2011)
MicroRNA-Based Classification of Hepatocellular Carcinoma and Oncogenic Role of miR-517a
Sara Toffanin et al.
GASTROENTEROLOGY (2011)
Tissue Biomarkers as Predictors of Outcome and Selection of Transplant Candidates With Hepatocellular Carcinoma
Josep M. Llovet et al.
LIVER TRANSPLANTATION (2011)
A novel interplay between oncogenic PFTK1 protein kinase and tumor suppressor TAGLN2 in the control of liver cancer cell motility
W. K. C. Leung et al.
ONCOGENE (2011)
Targeting Fibroblast Growth Factor Receptor Signaling in Hepatocellular Carcinoma
Ann-Lii Cheng et al.
ONCOLOGY (2011)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
Vincenzo Mazzaferro et al.
LANCET ONCOLOGY (2009)
Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties
C. Coulouarn et al.
ONCOGENE (2009)
Liver transplantation for hepatocellular carcinoma
Vincenzo Mazzaferro et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Recurrence of hepatocellular carcinoma following liver transplantation - A review of preoperative and postoperative prognostic indicators
Michael A. Zimmerman et al.
ARCHIVES OF SURGERY (2008)
Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2007)
Over-expression of c-raf-1 proto-oncogene in liver cirrhosis and hepatocellular carcinoma
YH Hwang et al.
HEPATOLOGY RESEARCH (2004)
The continuing increase in the incidence of hepatocellular carcinoma in the United States: An update
H El-Serag et al.
ANNALS OF INTERNAL MEDICINE (2003)
Time-dependent ROC curves for censored survival data and a diagnostic marker
PJ Heagerty et al.
BIOMETRICS (2000)
Share Paper
